Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer

  • Takashi Sasaki, Hiroyuki Isayama, Yousuke Nakai, Yukiko Ito, Hirofumi Kogure, Osamu Togawa, Nobuo Toda, Ichiro Yasuda, Osamu Hasebe, Iruru Maetani, Naoki Sasahira, Kenji Hirano, Takeshi Tsujino, Minoru Tada, Masao Omata
  • Cancer Chemotherapy and Pharmacology, August 2009, Springer Science + Business Media
  • DOI: 10.1007/s00280-009-1115-5

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1007/s00280-009-1115-5

The following have contributed to this page: Dr Yousuke Nakai